Altrius Capital Management Inc Purchases 71,209 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Altrius Capital Management Inc lifted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 39.9% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 249,487 shares of the pharmacy operator’s stock after buying an additional 71,209 shares during the quarter. Altrius Capital Management Inc’s holdings in Walgreens Boots Alliance were worth $3,018,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Pineridge Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $26,000. Quest Partners LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $30,000. 1832 Asset Management L.P. lifted its holdings in shares of Walgreens Boots Alliance by 282.1% in the fourth quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 900 shares in the last quarter. New Covenant Trust Company N.A. bought a new position in shares of Walgreens Boots Alliance during the first quarter worth $35,000. Finally, First Personal Financial Services grew its stake in Walgreens Boots Alliance by 260.0% during the first quarter. First Personal Financial Services now owns 1,800 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 1,300 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA opened at $9.01 on Thursday. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a 12 month low of $8.46 and a 12 month high of $27.05. The company has a market capitalization of $7.78 billion, a price-to-earnings ratio of -1.34, a PEG ratio of 1.02 and a beta of 0.70. The firm’s 50-day moving average is $10.40 and its 200 day moving average is $14.89.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same period in the prior year, the company posted $1.00 EPS. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. Research analysts predict that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were given a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 annualized dividend and a dividend yield of 11.10%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.84%.

Analysts Set New Price Targets

Several research firms have commented on WBA. JPMorgan Chase & Co. dropped their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Barclays cut their price target on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, July 23rd. Truist Financial decreased their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a report on Friday, June 28th. UBS Group cut their target price on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a report on Wednesday, July 3rd. Finally, Bank of America reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $14.73.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.